Data gathered: December 23
AI Stock Analysis - Abbott Laboratories (ABT)
Analysis generated October 15, 2024. Powered by Chat GPT.
Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States. It was founded by Chicago physician Wallace Calvin Abbott in 1888 to formulate known drugs; it is now a diversified healthcare giant with a market leading position in several domains such as diagnostics, medical devices, nutrition, and branded generic pharmaceuticals. Known for innovation and a strong portfolio of products, Abbott Laboratories has a significant impact on global healthcare markets.
Stock Alerts - Abbott Laboratories (ABT)
 |
Abbott Laboratories | December 20 Sentiment is up by 12.6% in the last couple of days. |
|
Abbott Laboratories | December 19 Michael McCaul (member of U.S. congress) is buying shares |
|
Abbott Laboratories | December 13 Sentiment is up by 10.5% in the last couple of days. |
|
Abbott Laboratories | December 8 Facebook engagement is up by 61.2% in the last 24h. |
Alternative Data for Abbott Laboratories
About Abbott Laboratories
Abbott Laboratories is a health care company that manufactures medical devices, blood glucose monitoring kits, nutritional healthcare products, diagnostic products and equipment, and branded generic drugs.
| Price | $113.76 |
| Target Price | Sign up |
| Volume | 1,490,000 |
| Market Cap | $198B |
| Year Range | $99.6 - $119.39 |
| Dividend Yield | 2.07% |
| PE Ratio | 34.72 |
| Analyst Rating | 85% buy |
| Industry | Health Care Services |
In the news
 |
Analysts Set Abbott Laboratories (NYSE:ABT) Price Target at $130.71December 22 - ETF Daily News |
 |
Abbott Laboratories' (NYSE:ABT) investors will be pleased with their respectable 43% return over the last five yearsDecember 21 - Yahoo |
|
M&T Bank Corp Has $110.42 Million Stock Position in Abbott Laboratories (NYSE:ABT)December 21 - ETF Daily News |
Abbott Laboratories: A Future-Driven Pharma Brand With A Robust PipelineDecember 20 - SeekingAlpha |
|
 |
The Zacks Analyst Blog Highlights Veracyte, Omnicell, Masimo and Abbott LaboratoriesDecember 19 - Yahoo |
Abbott Laboratories stock outperforms competitors on strong trading dayDecember 19 - MarketWatch |
|
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 10.6B | 8.06B | 2.58B | 1.65B | 2.33B | 1.210 |
| Q2 '24 | 10.4B | 8.01B | 2.37B | 1.3B | 2.14B | 1.140 |
| Q1 '24 | 9.82B | 7.9B | 1.92B | 1.23B | 2.05B | 0.980 |
| Q4 '23 | 10.1B | 8.26B | 1.8B | 1.59B | 2.44B | 1.190 |
| Q3 '23 | 9.99B | 7.82B | 2.16B | 1.44B | 2.33B | 1.140 |
Insider Transactions View All
| ALLEN HUBERT L filed to sell 340,978 shares at $118.8. October 23 '24 |
| ALLEN HUBERT L filed to sell 335,077 shares at $118.2. October 23 '24 |
| ALLEN HUBERT L filed to sell 184,806 shares at $117. October 23 '24 |
| Ford Robert B filed to sell 220,059 shares at $116.9. September 13 '24 |
| Ford Robert B filed to sell 281,439 shares at $116. September 13 '24 |
Similar companies
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Michael McCaul |
Dec 18, 24 | Buy | $50K - $100K |
| Michael McCaul |
Dec 18, 24 | Sell | $15K - $50K |
| Josh Gottheimer |
Sep 11, 24 | Buy | $1K - $15K |
Read more about Abbott Laboratories (ABT) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, news mentions, customer reviews, lobbying cost, business outlook & linkedin employees.
What is the Market Cap of Abbott Laboratories?
The Market Cap of Abbott Laboratories is $198B.
What is Abbott Laboratories' PE Ratio?
As of today, Abbott Laboratories' PE (Price to Earnings) ratio is 34.72.
What is the current stock price of Abbott Laboratories?
Currently, the price of one share of Abbott Laboratories stock is $113.76.
How can I analyze the ABT stock price chart for investment decisions?
The ABT stock price chart above provides a comprehensive visual representation of Abbott Laboratories' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Abbott Laboratories shares. Our platform offers an up-to-date ABT stock price chart, along with technical data analysis and alternative data insights.
Does ABT offer dividends to its shareholders?
Yes, Abbott Laboratories (ABT) offers dividends to its shareholders, with a dividend yield of 2.07%. This dividend yield represents Abbott Laboratories' commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering Abbott Laboratories in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.
What are some of the similar stocks of Abbott Laboratories?
Some of the similar stocks of Abbott Laboratories are HCA Healthcare, Cardinal Health, Henry Schein, Idexx Laboratories, and LabCorp.
.